𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Relapsed angioimmunoblastic T-cell lymphoma with acquired expression of CD20: a case report and review of the literature

✍ Scribed by Yara Banz, Fatime Krasniqi, Stephan Dirnhofer, Alexander Tzankov

Book ID
120683210
Publisher
BioMed Central
Year
2013
Tongue
English
Weight
649 KB
Volume
13
Category
Article
ISSN
1472-6890

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

CD30+ anaplastic large-cell lymphoma wit
CD30+ anaplastic large-cell lymphoma with aberrant expression of CD13: Case report and review of the literature
✍ Cherie H. Dunphy; Laura J. Gardner; Jose L. Manes; Christopher S. Bee; Kutay Tay πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 679 KB

CD13 is commonly expressed in hematopoietic malignancies of myelomonocytic origin and has less commonly been described in lymphoid neoplasms, including acute lymphoblastic leukemia, B-cell lymphoproliferative disorders, and plasma cell malignancies. Aberrant CD13 expression has rarely been described

CD8+ cutaneous T-cell lymphoma successfu
CD8+ cutaneous T-cell lymphoma successfully treated with bexarotene: A case report and review of the literature
✍ Srivalli Gopaluni; Raiza Perzova; Lynn Abbott; Ramsey Farah; Anthony Shrimpton; πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 132 KB πŸ‘ 2 views

## Abstract CD8+ cutaneous T‐cell lymphoma (CTCL) is a relatively rare subset of the non‐Hodgkins lymphomas. Bexarotene has been FDA‐approved for the treatment of CTCL, but previous studies have been conducted on CD4+ CTL and there have been no reports about its use in CD8+ CTCL. Herein, we report